Viewing Study NCT00381251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-05-29 @ 9:11 AM
Study NCT ID: NCT00381251
Status: COMPLETED
Last Update Posted: 2007-06-11
First Post: 2006-09-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Postmenopausal Osteoporosis View
None Postmenopause View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaginal atrophy View
None postmenopausal osteoporosis View
None menopause View
None hot flashes View